|
Re: as subtypes of her2+ breast cancer discovered, a particularly nasty one ID'd
It's probably worth noting, as frustrating as it is, that good ole standard Her2 testing seems to stil have some kinks to work out. The cutting edge lab pathology work is probably quite a ways from applicable.
|